New model forecasts cancer recurrence risk in rectal patients
NCT ID NCT07351708
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aimed to create a model that predicts whether rectal cancer will come back after treatment. Researchers looked at medical records and inflammation markers from over 2,300 patients with advanced rectal cancer who had chemotherapy or radiation before surgery. The goal was to help doctors identify patients at higher risk of local recurrence, so they can plan better follow-up care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED RECTAL CANCER (LARC) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.